Breaking News Instant updates and real-time market news.

AIG

AIG

$55.71

-0.44 (-0.78%)

, HIG

Hartford Financial

$60.65

0.17 (0.28%)

07:10
10/01/19
10/01
07:10
10/01/19
07:10

JPMorgan shifts Life Insurance view to negative from neutral

JPMorgan analyst Jimmy Bhullar shifted is view on the Life Insurance sector to negative from neutral ahead of the Q3 reporting season. His outlook for business fundamentals is "incrementally cautious" and he feels that consensus 2020 earnings estimates for most insurers are too high. In addition, stock prices do not seem to have reacted to the decline in interest rates, Bhullar tells investors in a research note. The analyst lowered his estimates for most companies, and his numbers for 2020 are now "considerably below" consensus on AIG (AIG), Hartford Financial (HIG), and Voya Financial (VOYA), but slightly above for Aflac (AFL) and Unum Group (UNM). For Q3, Bhullar thinks consensus estimates for Athene Holding (ATH) and Reinsurance Group (RGA) are" especially high," while numbers for Principal Financial (PFG) "seem conservative." Globe Life (GL) and Lincoln National (LNC) are the analyst's top picks and he remains negative on Brighthouse Financial (BHF).

AIG

AIG

$55.71

-0.44 (-0.78%)

HIG

Hartford Financial

$60.65

0.17 (0.28%)

VOYA

Voya Financial

$54.44

-0.31 (-0.57%)

AFL

Aflac

$52.32

0.43 (0.83%)

UNM

Unum Group

$29.71

0.15 (0.51%)

ATH

Athene Holding

$42.09

-0.47 (-1.10%)

RGA

Reinsurance Group

$159.92

-0.71 (-0.44%)

PFG

Principal Financial

$57.17

-0.22 (-0.38%)

GL

Globe Life

$95.66

-0.38 (-0.40%)

LNC

Lincoln National

$60.33

-0.59 (-0.97%)

BHF

Brighthouse Financial

$40.45

-0.1 (-0.25%)

  • 10

    Oct

  • 25

    Oct

  • 31

    Oct

  • 31

    Oct

  • 11

    Nov

  • 20

    Nov

  • 21

    Nov

  • 11

    Dec

AIG AIG
$55.71

-0.44 (-0.78%)

08/09/19
RBCM
08/09/19
NO CHANGE
Target $68
RBCM
Outperform
AIG price target raised to $68 from $60 at RBC Capital
RBC Capital analyst Mark Dwelle raised his price target on AIG to $68 and kept his Outperform rating after its Q2 results, saying this was the "breakout quarter" for the company with strong earnings growth and "noteworthy" margin improvement. The analyst contends that AIG's pricing trends in P&C are gaining strength as its repositioning efforts continue.
08/08/19
JPMS
08/08/19
NO CHANGE
JPMS
Neutral
AIG results not as strong as they appear, says JPMorgan
AIG reported "health" Q2 results, but they are not as strong as they appear, JPMorgan analyst Jimmy Bhulla tells investors in a post-earnings research note. AIG's earnings beat forecasts, but core business trends were "lackluster," says the analyst. He keeps a Neutral rating on the shares and leaves his estimates unchanged despite the airings beat in Q2. Bhulla views AIG's fundamental outlook as mixed and continues to have concerns about downside risk to consensus estimates.
07/18/19
WBLR
07/18/19
UPGRADE
WBLR
Outperform
AIG upgraded to Outperform from Market Perform at William Blair
07/19/19
WBLR
07/19/19
UPGRADE
WBLR
Outperform
William Blair upgrades AIG to Outperform on shift to 'earnings growth mode'
William Blair analyst Adam Klauber last night upgraded AIG to Outperform from Market Perform saying the company is beginning to "shift to earnings growth mode." Management has laid the groundwork for a long-term rebound with "significant mix repositioning, a shift in underwriting strategy, and de-risking of the investment portfolio," Klauber told investors in a research note. These factors, along with improving competitive conditions, suggest positive momentum at AIG is more likely going forward, contends the analyst. He believes the company's earnings per share are on pace to approach the $7.00 level by 2021. A price-to-earnings multiple of 12 times a 2021 operating earnings per share estimate of $6.70 implies the stock could increase roughly 45% over the next several years, according to Klauber.
HIG Hartford Financial
$60.65

0.17 (0.28%)

05/29/19
05/29/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Flex (FLEX) upgraded to Overweight from Neutral at JPMorgan with analyst Paul Coster citing valuation. 2. Allstate (ALL) and Hartford Financial (HIG) were upgraded to Buy from Neutral at Goldman Sachs. 3. Rockwell Automation (ROK) upgraded to Buy from Hold at Gabelli with analyst Justin Bergner saying the negative investor sentiment stemming from "skepticism" of its software partnership strategy and the decline in the relevance of its programmable logic controller is unwarranted. 4. Falcon Minerals (FLMN) upgraded to Buy from Hold at Stifel with analyst Timothy Howard saying Falcon shares have underperformed over the last 30 days, falling 17% compared to peers down 6% and crude oil prices down 7%. 5. YY (YY) upgraded to Buy from Neutral at Nomura Instinet with t analyst Jialong Shi saying the risk/reward is more favorable with the stock down 27% from its recent peak. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/05/19
RBCM
08/05/19
NO CHANGE
Target $68
RBCM
Outperform
Hartford Financial price target raised to $68 from $61 at RBC Capital
RBC Capital analyst Mark Dwelle raised his price target on Hartford Financial to $68 and kept his Outperform rating, saying the company posted "good core results" in Q2 with low 90s underlying combined ratios for both commercial and personal lines. The analyst also notes that the former is generating accelerating pricing trends, and the management commentary suggests the integration of Navigators and the company's growth plans are "proceeding well".
05/29/19
GSCO
05/29/19
UPGRADE
Target $64
GSCO
Buy
Hartford Financial upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Yaron Kinar upgraded Hartford Financial to Buy from Neutral and raised his price target for the shares to $64 from $53. The analyst execs the company's property and casualty margins to be stable on both an accident year basis and calendar year basis. He also models a "modest earnings lift" from the acquisition of Navigators.
07/19/19
BUCK
07/19/19
NO CHANGE
BUCK
Buckingham upgrades Axis Capital, downgrades Arch, Travelers ahead of earnings
As previously reported, Buckingham analyst Amit Kumar upgraded Axis Capital (AXS) to Buy from Neutral and downgraded Arch Capital (ACGL) and Travelers (TRV), both to Neutral from Buy, ahead of Q2 earnings for the insurance/reinsurance space. He believes that Axis' relative discount is no longer justified given positive pricing commentary in reinsurance and E&S markets and his analysis of reserves and he thinks the stock is best positioned to catch up to its peer group, Kumar said in his sector preview note. He raised his price target on Axis shares to $70 from $60. Arch currently trades above its 5 year average multiple to next twelve months consensus book value and he feels the stock is fully priced, said Kumar, who keeps a $38 price target on the stock. In terms of Travelers, Kumar also cites valuation and recommends that investors rotate into Hartford Financial (HIG) given its valuation discount and the fact that it should also benefit from rate increases.
VOYA Voya Financial
$54.44

-0.31 (-0.57%)

08/07/19
MSCO
08/07/19
NO CHANGE
Target $64
MSCO
Overweight
Voya target lowered to $64 at Morgan Stanley after 'somewhat disappointing' Q2
Morgan Stanley analyst Nigel Dally said he viewed Voya Financial's second quarter as "somewhat disappointing" after the company had been on a run of delivering strong EPS growth, solid ROE expansion and returning a substantial amount of capital to investors. However, most of the shortfall in core results in Q2 driven by adverse mortality, which should be temporary in nature, said Dally. He trimmed his price target on Voya shares to $64 from $66 but keeps an Overweight rating on the stock.
09/12/19
GSCO
09/12/19
UPGRADE
Target $68
GSCO
Conviction Buy
Voya Financial upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman Sachs analyst Alex Scott added Voya Financial (VOYA) to his firm's Americas Conviction List while maintaining a Buy rating on the shares. He also raised his price target for the shares to $68 from $59. Voya has a better ability to beat earnings estimates in the near term as well as in 2020 and 2021 relative to Prudential Financial (PRU), Scott tells investors in a research note. He believes expense reduction, share count reduction, and the addition of a large record keeping contract earn in can drive the upside for Voya.
09/12/19
GSCO
09/12/19
DOWNGRADE
Target $99
GSCO
Buy
Prudential downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Alex Scott removed Prudential Financial (PRU) from his firm's Americas Conviction List while maintaining a Buy rating on the shares. The analyst also lowered his price target for the stock to $99 from $107. Voya Financial (VOYA) has a better ability to beat earnings estimates in the near term as well as in 2020 and 2021 relative to Prudential, Scott tells investors in a research note. While a good amount "near-term negativity" is already priced into Prudential, the shares do not have many catalysts in the next six months outside of earnings beats, adds the analyst. He sees a more challenging near-term setup for Prudential and shifts his conviction to Voya.
09/12/19
09/12/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. PayPal (PYPL) assumed at Buy, up from Hold at Canaccord with analyst Joseph Vafi saying PayPal is a "payments juggernaut," and its growth in payment volumes "at this scale is impressive." 2. Activision Blizzard (ATVI) upgraded to Buy from Neutral at Nomura Instinet with analyst Andrew Marok saying last month's launch of World of Warcraft Classic has driven "strong, above-expectations" engagement in the franchise. 3. Voya Financial (VOYA) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alex Scott saying Voya has a better ability to beat earnings estimates in the near term as well as in 2020 and 2021 relative to Prudential Financial (PRU). 4. AbbVie (ABBV) upgraded to Buy from Neutral at UBS with analyst Navin Jacob saying he sees the company's acquisition of Allegan as "highly compelling," with NewCo generating over $20B of annual free cash flow and a 9% yield by 2023 when its Humira exclusivity patent expires. 5. Kaman (KAMN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Steve Barger citing meetings with management. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AFL Aflac
$52.32

0.43 (0.83%)

08/21/19
EVER
08/21/19
NO CHANGE
EVER
Underperform
Aflac third sector sales estimate at risk due to Japan Post, says Evercore ISI
After the Mainichi reported that sources close to the company believe Japan Post mis-sold 104,000 Aflac cancer insurance policies, Evercore ISI analyst Thomas Gallagher called this a surprise, noting that both Aflac and Japan Post previously said they did not believe those policies were part of the sales mispractices found at Japan Post. He wouldn't be surprised if Aflac polices were suspended through Japan Post, at least until the systems issues are rectified, and said a "more severe outcome" would be if Japan Post includes a broader suspension of Aflac cancer sales until it completes its entire review. Gallagher, who said there may be some risk to his current third sector sales estimate of an 11% decline in 2019, keeps an Underperform rating on Aflac shares.
09/09/19
SBSH
09/09/19
NO CHANGE
SBSH
Sell
Citi opens 'Negative Catalyst Watch' on Aflac ahead of analyst briefing
Citi analyst Suneet Kamath opened a "Negative Catalyst Watch" on shares of Aflac ahead of the company's Financial Analyst Briefing meeting. The analyst believes Aflac will guide to ongoing pressure on Japan sales in 2020 and points out that the stock has generally underperformed around prior FAB meetings. Further, Kamath believes current consensus estimates already reflect margins and capital return toward the high-end of prior guidance. He lowered his 2020 earnings per share estimate to $4.40 from $4.45 and dropped his price target for the shares to $44 from $45. The analyst keeps a Sell rating on Aflac.
07/29/19
RAJA
07/29/19
DOWNGRADE
Target $62
RAJA
Outperform
Raymond James downgrades Aflac to Outperform on Japan Post issues
As previously reported, Raymond James analyst Gregory Peters downgraded Aflac to Outperform from Strong Buy, stating that its near-term sales outlook in Japan will be challenged as Japan Post works through allegations of agent misconduct that could limit new sales through the end of the year. Japan Post accounted for about 25% of Aflac Japan's third sector sales in 2018 and the companies announced an expanded relationship last year, noted Peters, who keeps a $62 price target on Aflac shares.
07/29/19
RAJA
07/29/19
DOWNGRADE
Target $62
RAJA
Outperform
Aflac downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst Gregory Peters downgraded Aflac to Outperform from Strong Buy with a $62 price target citing valuation.
UNM Unum Group
$29.71

0.15 (0.51%)

07/10/19
FBCO
07/10/19
INITIATION
Target $19
FBCO
Underperform
Unum Group initiated with an Underperform at Credit Suisse
Credit Suisse analyst Andrew Kligerman started Unum Group with an Underperform rating and $19 price target. The analyst estimates the company's long-term care insurance block faces a $5.7B after-tax reserve deficiency at net present value. This is despite favorable adjustments to assumed incidence and aging curves based on Unum Group feedback, which if not indicative, suggests up to a $14.3B deficiency, Kligerman tells investors in a research note. He believes investor concern may arise from charges at other long-term care writers and potential long-term care-driven insolvencies.
01/09/19
LEHM
01/09/19
NO CHANGE
LEHM
Barclays downgrades Life Insurance sector to Neutral from Positive
Barclays analyst Jay Gelb downgraded the U.S. Life Insurance sector to Neutral from Positive because he doubts valuations will improve in a volatile environment. A sub-3% yield on 10-year Treasuries, a flat yield curve, declining equity markets and long-term care insurance risks are viewed as factors in the "substantial de-rating of life insurer valuations," Gelb tells investors in a research note. The analyst prefers the Property and Casualty sector based on its "lower beta and less exposure to a volatile macro environment." As part of the sector rating change, the analyst upgraded Ameriprise Financial (AMP) to Overweight from Equal Weight. He also continues to see value in Prudential (PRU), Unum Group (UNM) and Lincoln National (LNC). His Underweight rated names are Brighthouse Financial (BHF) and Torchmark (TMK).
ATH Athene Holding
$42.09

-0.47 (-1.10%)

05/21/19
FBCO
05/21/19
NO CHANGE
Target $57
FBCO
Outperform
Athene Holding price target lowered to $57 from $67 at Credit Suisse
Credti Suisse analyst Andrew Kligerman lowered his price target for Athene Holding to $57 from $67 on a change in his risk premium to more conservatively reflect investment risk. The analyst reiterates an Outperform rating on the shares.
02/27/19
BMOC
02/27/19
UPGRADE
Target $62
BMOC
Outperform
Athene Holding upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst James Fotheringham upgraded Athene Holding on valuation but also lowered his price target to $62 from $69. The analyst contends that the valuation multiple on the stock may have finally passed its trough at its current 5.5-times two-year forward earnings multiple and believes that its core business should be valued at 6.4-times. Fotheringham also cites Athene Holdings' strong track record of growth-by-acquisition, assigning it with forward excess capital value in his model.
02/28/19
02/28/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Fitbit (FIT) upgraded to Buy from Neutral at DA Davidson analyst Tom Forte citing Q4 results and outlook for Q1 and FY19. 2. Hain Celestial (HAIN) upgraded to Overweight from Neutral at JPMorgan with analyst Ken Goldman citing the company's "compelling" investor day, the analyst has increased confidence in Hain's ability to drive margin growth over the next few years. 3. Athene Holding (ATH) upgraded to Outperform from Market Perform at BMO Capital with analyst James Fotheringham saying the valuation multiple on the stock may have finally passed its trough at its current 5.5-times two-year forward earnings multiple and believes that its core business should be valued at 6.4-times. 4. Wabco (WBC) upgraded to Neutral from Underweight at JPMorgan and to Hold from Sell at Vertical Research. 5. Globus Medical (GMED) upgraded to Buy from Neutral at UBS with analyst Matthew Taylor saying the company has delivered several quarters in a row of improving spine growth, which confirms robot placements are leading to implant pull-through. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/30/19
SDLR
04/30/19
DOWNGRADE
SDLR
Hold
American Equity downgraded to Hold on no-deal risk at Sandler O'Neill
As previously reported, Sandler O'Neill analyst John Barnidge downgraded American Equity (AEL) to Hold from Buy as he sees greater downside risk than upside potential for shares if the company provides any commentary with Q1 earnings that its process has ended with no sale about one year after the company first acknowledged market rumors of a transaction. In such a case, Barnidge thinks investors would look to the valuation multiples of Athene Holding (ATH) and FGL Holdings (FG) as proxies, he said.
RGA Reinsurance Group
$159.92

-0.71 (-0.44%)

12/11/18
RBCM
12/11/18
UPGRADE
RBCM
Outperform
Reinsurance Group upgraded to Outperform from Sector Perform at RBC Capital
06/03/19
SBSH
06/03/19
NO CHANGE
SBSH
Citi recommends focusing on pair trades in Life Insurance
Citi analyst Suneet Kamath believes investors should consider pair trades within the U.S. Life & Health Insurance space. The analyst favors Voya Financial (VOYA) over Principal Financial Group (PFG), Lincoln National (LNC) over Brighthouse Financial (BHF), and Reinsurance Group (RGA) over Aflac (AFL).
12/11/18
RBCM
12/11/18
UPGRADE
Target $165
RBCM
Outperform
Reinsurance Group upgraded to Outperform from Sector Perform at RBC Capital
As reported earlier, RBC Capital analyst Kenneth Lee upgraded Reinsurance Group to Outperform and raised his price target to $165 from $150. The analyst is positive on the company's "competitive position as one of the largest global life reinsurers", along with its role as the only "pure-play publicly-traded U.S. life reinsurer". Lee also cites Reinsurance Group's "experienced management team with expertise in assessing/pricing reinsurance risks" along with its "very attractive" valuation.
PFG Principal Financial
$57.17

-0.22 (-0.38%)

04/29/19
RBCM
04/29/19
NO CHANGE
Target $55
RBCM
Sector Perform
Principal Financial price target raised to $55 from $49 at RBC Capital
RBC Capital analyst Mark Dwelle raised his price target on Principal Financial to $55, saying its Q1 results exceeded expectations in terms of cash flows in all units and "strong sales". The analyst is keeping his Sector Perform rating however, citing the impact of corporate expenses that contributed to earnings declines relative to last year's Q1 across all units.
02/05/19
UBSW
02/05/19
DOWNGRADE
Target $45
UBSW
Sell
Principal Financial downgraded to Sell from Neutral at UBS
UBS analyst John Nadel downgraded Principal Financial Group (PFG) to Sell and lowered his price target for the shares to $45 from $46. Consensus estimates remain too high and do not appropriately reflect seasonal weakness typical of Principal's Q1 results, Nadel tells investors in a research note. The analyst views the shares as "currently overvalued" given the company's market pressures in the nearer term and competitive dynamics over the longer term. He prefers shares of Ameriprise Financial (AMP) and Voya Financial (VOYA) to Principal Financial.
01/09/19
EVER
01/09/19
DOWNGRADE
Target $48
EVER
In Line
Principal Financial downgraded to In Line from Outperform at Evercore ISI
As reported earlier Evercore ISI analyst Thomas Gallagher downgraded Principal Financial to In Line and lowered his price target to $48 from $58 as part of his broader research note on US and Global Life insurers. The analyst notes that the stock trades at a modest premium based on his 10.5-times forward free cash flow estimate multiple, saying that its valuation is looks "full". Gallagher cites a "potential catalyst" for Principal Financial would be a "recovery in asset management and life insurance valuations" but sees its risk/reward on a relative basis as "properly balanced."
GL Globe Life
$95.66

-0.38 (-0.40%)

09/20/19
FBCO
09/20/19
INITIATION
Target $114
FBCO
Outperform
Globe Life initiated with an Outperform at Credit Suisse
Credit Suisse analyst Andrew Kligerman started Globe Life with an Outperform rating and $114 price target. The analyst projects 5% annual premium growth and believes the company's life and P&C personal lines outlooks are superior relative to peers.
LNC Lincoln National
$60.33

-0.59 (-0.97%)

07/12/19
SBSH
07/12/19
NO CHANGE
SBSH
Citi opens 'Negative Catalyst Watches' on MetLife and Prudential
Citi analyst Suneet Kamath opened "Negative Catalyst Watches" on both MetLife (MET) and Prudential (PRU). He believes 2020 consensus estimates look too high for Sell-rated MetLife. On Buy-rated Prudential, the analyst believes the company's Q2 assumption review could drive a charge in Individual Life and lower the segment's run-rate earnings power. Kamath favors "equity sensitive names" and stocks at "below average" valuation multiples into the Q2 earnings season, namely Ameriprise (AMP), Lincoln National (LNC) and Voya Financial (VOYA).
06/25/19
06/25/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. GrubHub (GRUB) upgraded to Buy from Neutral at Citi with analyst Mark May citing five primary factors he sees to be more bullish on the stock. 2. Gates Industrial (GTES) upgraded to Buy from Neutral at Goldman Sachs with analyst Jerry Revich saying the stock is down 46% from its highs of September of 2018, which he attributes to multiple compression amid negative estimate revisions due to destocking in the after-market channel and a slowdown in original equipment demand. 3. GasLog (GLOG) upgraded to Buy from Hold at Stifel with analyst Benjamin Nolan citing both valuation and his expectation for strong LNG charter rates in the second half of the year. 4. SiteOne Landscape (SITE) upgraded to Outperform from Neutral at Baird with analyst David Manthey saying weather may impact Q2 but he believes the short interest has already been priced in. 5. Lincoln National (LNC) upgraded to Buy from Neutral at Goldman Sachs with analyst Alex Scott citing the upside to earnings he sees in the group benefits segment following the company's acquisition and integration of the Liberty business, the higher economic value of the variable annuity business, the company's "strong" distribution platform and the earnings tailwind he expects from the company's digital investments. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/25/19
GSCO
06/25/19
UPGRADE
Target $77
GSCO
Buy
Lincoln National upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Alex Scott upgraded Lincoln National to Buy from Neutral with a $77 price target, citing the upside to earnings he sees in the group benefits segment following the company's acquisition and integration of the Liberty business, the higher economic value of the variable annuity business, the company's "strong" distribution platform and the earnings tailwind he expects from the company's digital investments. Despite the headwind from lower interest rates, Scott thinks Lincoln National shares will rise if management hits their targets, he tells investors.
BHF Brighthouse Financial
$40.45

-0.1 (-0.25%)

06/25/19
06/25/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tiffany (TIF) downgraded to Hold from Buy at Loop Capital with analyst Laura Champine saying she believes weak tourist traffic continues to impact global demand levels, adding that she is "concerned" that same-store sales growth may prove more difficult to achieve as the company laps its paper flowers launch. 2. GasLog Partners (GLOP) downgraded to Hold from Buy at Stifel with analyst Benjamin Nolan citing valuation and the announcement of an agreement to eliminate the GP's incentive distribution rights in exchange for newly issued limited partner units at a price that Nolan estimates "to be higher than necessary." 3. Kellogg (K) downgraded to Underweight from Equal Weight at Consumer Edge. 4. Delek US (DK) downgraded to Sell from Neutral at Goldman Sachs with analyst Neil Mehta saying the stock has risen 28% since June amid a favorable crude spread between Brent and Midland. 5. Brighthouse Financial (BHF) downgraded to Underperform from Neutral at Credit Suisse and to Sell from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/25/19
FBCO
06/25/19
DOWNGRADE
Target $22
FBCO
Underperform
Brighthouse Financial downgraded to Underperform from Neutral at Credit Suisse
Credit Suisse analyst Andrew Kligerman downgraded Brighthouse Financial to Underperform from Neutral and cut the price target to $22 from $35.
06/25/19
GSCO
06/25/19
DOWNGRADE
Target $32
GSCO
Sell
Brighthouse Financial downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Alex Scott downgraded Brighthouse Financial to Sell from Neutral and lowered his price target on the shares to $32 from $39 as he believes the company's capital plans may come under pressure. Lower interest rates may result in little to no distributable earnings from the variable annuity business, he does not see a material redundancy in the universal life captive and there is still regulatory risk from the updated VA Capital Reform and deductible approach to hedging, all of which will make it harder for subsidiary Brighthouse Life Insurance to begin making ordinary cash remittances to the holding company, Scott tells investors.
06/25/19
06/25/19
DOWNGRADE
Target $22

Underperform
Brighthouse Financial downgraded to Underperform on risk at Credit Suisse
As previously reported, Credit Suisse analyst Andrew Kligerman downgraded Brighthouse Financial to Underperform from Neutral on risk, and lowered his price target on the shares to $22 from $35. The analyst believes the stock appears expensive given its volatile distributable earnings and new accounting pressure.

TODAY'S FREE FLY STORIES

MGTA

Magenta Therapeutics

$12.99

-0.14 (-1.07%)

05:03
12/06/19
12/06
05:03
12/06/19
05:03
Initiation
Magenta Therapeutics initiated  »

Magenta Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

ODT

Odonate Therapeutics

$33.29

-1.75 (-4.99%)

05:02
12/06/19
12/06
05:02
12/06/19
05:02
Initiation
Odonate Therapeutics initiated  »

Odonate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNSA

Kiniksa

$10.01

-0.1 (-0.99%)

05:00
12/06/19
12/06
05:00
12/06/19
05:00
Upgrade
Kiniksa rating change  »

Kiniksa assumed to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMED

Amedisys

$165.41

-1.22 (-0.73%)

04:58
12/06/19
12/06
04:58
12/06/19
04:58
Initiation
Amedisys initiated  »

Amedisys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$46.09

-0.49 (-1.05%)

04:56
12/06/19
12/06
04:56
12/06/19
04:56
Downgrade
Sanofi rating change  »

Sanofi downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

CDEV

Centennial Resource Development

$3.41

0.06 (1.79%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Downgrade
Centennial Resource Development rating change  »

Centennial Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$3.93

-0.135 (-3.32%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Downgrade
Encana rating change  »

Encana downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNS

Cadence Design

$65.77

-0.15 (-0.23%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Cadence Design management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SPGI

S&P Global

$271.33

2.81 (1.05%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
S&P Global management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Jan

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Wolfe Research healthcare analysts to hold an analyst/industry webcast »

Healthcare Analysts…

FTNT

Fortinet

$104.92

1.37 (1.32%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Fortinet management to meet with Oppenheimer »

Meetings with Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

  • 08

    Jan

KMPR

Kemper

$73.65

-0.76 (-1.02%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Kemper management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 11

    Dec

  • 12

    Dec

EXTR

Extreme Networks

$6.80

-0.08 (-1.16%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Extreme Networks management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 10

    Dec

AXP

American Express

$118.31

0.32 (0.27%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
American Express management to meet with William Blair »

Group Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

OPRT

Oportun Financial

$20.13

0.11 (0.55%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Oportun Financial management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ILPT

Industrial Logistics Property Trust

$21.98

-0.515 (-2.29%)

, CBM

Cambrex

$59.99

(0.00%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Hot Stocks
Industrial Logistics Property to replace Cambrex in S&P 600 at open on 12/6 »

Permira Advisors is…

ILPT

Industrial Logistics Property Trust

$21.98

-0.515 (-2.29%)

CBM

Cambrex

$59.99

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNLO

Menlo Therapeutics

$4.20

0.2 (5.00%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Menlo Therapeutics management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MELI

MercadoLibre

$578.24

3.3 (0.57%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
MercadoLibre management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 17

    Dec

  • 17

    Dec

DSGX

Descartes Systems

$40.85

-1.59 (-3.75%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Descartes Systems management to meet with Wolfe Research »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MPWR

Monolithic Power

$162.23

0.24 (0.15%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Monolithic Power management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ENLAY

Enel

$0.00

(0.00%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Enel management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

WNC

Wabash

$15.51

0.17 (1.11%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Wabash management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
Macquarie to hold a conference »

Asia Internet, Media and…

AZPN

Aspen Technology

$120.26

-0.95 (-0.78%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Recommendations
Aspen Technology analyst commentary  »

Aspen Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 12

    Dec

AAON

AAON

$49.14

0.78 (1.61%)

04:55
12/06/19
12/06
04:55
12/06/19
04:55
Conference/Events
AAON management to meet with Sidoti »

Meetings with Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.